Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-07T10:40:37.887Z Has data issue: false hasContentIssue false
  • English
  • Français

Estimated Values of Avoiding Cancer Risks by Cancer Site and Population

Published online by Cambridge University Press:  30 January 2025

Matthew LaPenta ,
Lauren Masatsugu ,
L. Elizabeth Riess  and
Emma Glidden-Lyon
Matthew LaPenta*
Affiliation:
Abt Global, Cambridge, MA, USA
Lauren Masatsugu
Affiliation:
Abt Global, Cambridge, MA, USA
L. Elizabeth Riess
Affiliation:
Abt Global, Cambridge, MA, USA
Emma Glidden-Lyon
Affiliation:
Abt Global, Cambridge, MA, USA
*
Corresponding author: Matthew LaPenta; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

In this paper, we present a standardized approach for using cancer incidence and survival data to account for the timing between a reduction in carcinogen exposure and the subsequent reduction in cancer risk and fatality. While the estimates for this timing between a reduction in carcinogen exposure and reduced cancer risk would ideally come from high-quality studies specifically examining this question, very few such studies are available. Thus, we designed an approach to account for this timing when sufficient data are not available elsewhere. Our approach can be used in estimating monetized values for achieving small reductions in the risks for many common specific types of cancer in benefit–cost analyses of regulatory and non-regulatory policies in the United States that achieve cancer risk reductions by reducing carcinogen exposures. We provide estimated values for 108 different cancer sites and for all cancer sites combined. We accompany this paper with a spreadsheet-based tool that presents our results separately for non-fatal and fatal risks so that results can easily be calculated using different combinations of discount rates, latency between carcinogen exposure and cancer diagnosis, values for the willingness-to-pay to avoid fatal and non-fatal cancer risks, and potentially affected populations.

Keywords

carcinogen exposurediscountingwillingness-to-paycancercessation lagcancer risklatency
Type
Article
Information
Journal of Benefit-Cost Analysis , First View , pp. 1 - 45
Copyright
© Abt Global LLC, 2025. Published by Cambridge University Press on behalf of Society for Benefit-Cost Analysis

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abt Associates. 2022. “Estimated Values of Avoiding Cancer Risks by Cancer Site and Population.” Abt Associates. Rockville, MD. Available at: https://www.regulations.gov/document/EPA-HQ-OPPT-2020-0720-0167.Google Scholar
Adamowicz, Wiktor, Dupont, Diane, Krupnick, Alan, and Zhang, Jing. 2011. “Valuation of Cancer and Microbial Disease Risk Reductions in Municipal Drinking Water: An Analysis of Risk Context Using Multiple Valuation Methods.” Journal of Environmental Economics and Management, 61(2): 213–226.CrossRefGoogle Scholar
Ahn, Yeon-Soon and Jeong, Kyoung Sook .2014. “Epidemiologic Characteristics of Compensated Occupational Lung Cancers Among Korean Workers.” Journal of Korean Medical Science, 29(11): 1473–1481.CrossRefGoogle ScholarPubMed
Ahn, Yeon-Soon and Kang, Seong-Kyu. 2009. “Asbestos-Related Occupational Cancers Compensated Under the Industrial Accident Compensation Insurance in Korea.” Industrial Health, 47(2): 113–122.CrossRefGoogle ScholarPubMed
Alberini, Anna, Rheinberger, Christoph M., and Ščasný, Milan. 2023. “All Cancers Are not Created Equal: How Do Survival Prospects Affect the Willingness to Pay to Avoid Cancer?” Journal of Benefit-Cost Analysis, 14(1): 93–113.CrossRefGoogle Scholar
Alberini, Anna and Scasny, Milan. 2010. Does the Cause of Death Matter? The Effect of Dread, Controllability, Exposure and Latency on the VSL. FEEM working paper No. 139.Google Scholar
Alberini, Anna and Scasny, Milan. 2018. “The Benefits of Avoiding Cancer (or Dying from Cancer): Evidence From a Four-Country Study.” Journal of Health Economics, 57: 249–262.CrossRefGoogle ScholarPubMed
Andersen, H. C., Andersen, I., and Solgaard, J.. 1977. “Nasal Cancers, Symptoms and Upper Airway Function in Woodworkers.” British Journal of Industrial Medicine, 34(3): 201–207.Google ScholarPubMed
Archer, Victor E., Coons, Teresa, Saccomanno, Geno, and Hong, Dae-Yong. 2004. “Latency and the Lung Cancer Epidemic Among United States Uranium Miners.” Health Physics, 87(5): 480–489.CrossRefGoogle ScholarPubMed
Argo, J. 2010. “Chronic Diseases and Early Exposure to Airborne Mixtures: Part III. Potential Origin of Pre-Menopausal Breast Cancers.” Journal of Exposure Science & Environmental Epidemiology, 20(2): 147–159.CrossRefGoogle ScholarPubMed
Barthel, E. 1976. “High Incidence of Lung Cancer in Persons With Chronic Professional Exposure to Pesticides in Agriculture (Author’s Transl).” Zeitschrift fur Erkrankungen der Atmungsorgane, 146(3): 266–274.Google ScholarPubMed
Beck, Bernd, Konetzke, Gerhard, Ludwig, Volker, Rothig, Werner, and Sturm, Wolf. 1982. “Malignant Pericardial Mesotheliomas and Asbestos Exposure: A Case Report.” American Journal of Industrial Medicine, 3(2): 149–159.CrossRefGoogle ScholarPubMed
Bell, Felicitie C and Miller, Michael L.. 2015. “Life Tables for the United States Social Security Area 1900-2100 (Period Life Table, 2016). Actuarial Study, 120.”Google Scholar
Bender, A. P., Parker, D. L., Johnson, R. A., Scharber, W. K., Williams, A. N., Marbury, M. C., and Mandel, J. S.. 1989. “Minnesota Highway Maintenance Worker Study: Cancer Mortality.” American Journal of Industrial Medicine, 15(5): 545–556.CrossRefGoogle ScholarPubMed
Bianchi, Claudio and Bianchi, Tommaso. 2009. “Malignant Pleural Mesothelioma in Italy.” Indian Journal of Occupational and Environmental Medicine, 13(2): 80–83.CrossRefGoogle ScholarPubMed
Bianchi, Claudio and Bianchi, Tommaso. 2012. “Mesothelioma Among Shipyard Workers in Monfalcone, Italy.” Indian Journal of Occupational and Environmental Medicine, 16(3): 119–123.CrossRefGoogle ScholarPubMed
Bianchi, Claudio, Bianchi, Tommaso, and Bucconi, Sergio. 2011. “Malignant Mesothelioma of the Pleura in Nonagenarian Patients.” Tumori, 97(2): 156–159.CrossRefGoogle ScholarPubMed
Bianchi, Claudio, Brollo, Alessandro, Ramani, Lucia, Bianchi, Tommaso, and Giarelli, Luigi. 2004. “Familial Mesothelioma of the Pleura—A Report of 40 Cases.” Industrial Health, 42(2): 235–239.CrossRefGoogle ScholarPubMed
Bosworth, Ryan, Cameron, Trudy Ann, and DeShazo, J. R.. 2009. “Demand for Environmental Policies to Improve Health: Evaluating Community-Level Policy Scenarios.” Journal of Environmental Economics and Management, 57(3): 293–308.CrossRefGoogle Scholar
Bosworth, Ryan, Cameron, Trudy Ann, and DeShazo, J. R.. 2010. “Is an Ounce of Prevention Worth a Pound of Cure? Comparing Demand for Public Prevention and Treatment Policies.” Medical Decision Making, 30(4): E40–E56.CrossRefGoogle Scholar
Brims, F., Kumarasamy, C., Menon, L., Olsen, N., de Klerk, N., and Franklin, P.. 2023. “The Western Australian Mesothelioma Registry: Analysis of 60 Years of Cases.” Respirology, 29(4): 288–294.CrossRefGoogle ScholarPubMed
Burdorf, Alex, Dahhan, Mohssine, and Swuste, Paul. 2003. “Occupational Characteristics of Cases With Asbestos-Related Diseases in The Netherlands.” Annals of Occupational Hygiene, 47(6): 485–492.Google ScholarPubMed
Cameron, Trudy Ann. 2014. “Valuing Morbidity in Environmental Benefit-Cost Analysis.” Annual Review of Resource Economics, 6(1): 249–272.CrossRefGoogle Scholar
Cameron, Trudy Ann and DeShazo, JR. 2013. “Demand for Health Risk Reductions.” Journal of Environmental Economics and Management, 65(1): 87–109.CrossRefGoogle Scholar
Cansurv, Version 1.4. 2017. Statistical Research and Applications Branch. Rockville, MD: National Cancer Institute.Google Scholar
Centers for Disease Control and Prevention (CDC). 2023. “Cancer Data and Statistics,” December 4, 2023. https://www.cdc.gov/cancer/dcpc/data/index.htm.Google Scholar
Chahinian, A. Philippe, Pajak, Thomas F., Holland, James F., Norton, Larry, Ambinder, Roy M., and Mandel, Eugen M.. 1982. “Diffuse Malignant Mesothelioma. Prospective Evaluation of 69 Patients.” Annals of Internal Medicine, 96(6 Pt 1): 746–755.CrossRefGoogle ScholarPubMed
Chang, Kwok C., Leung, Chi C., Tam, Cheuk M., Yu, Wai C., Hui, David S., and Lam, Wah K.. 2006. “Malignant Mesothelioma in Hong Kong.” Respiratory Medicine, 100(1): 75–82.CrossRefGoogle ScholarPubMed
Collins, J. J., Jammer, B., Sladeczek, F. M., Bodnar, C. M., and Salomon, S. S.. 2014. “Surveillance for Angiosarcoma of the Liver Among Vinyl Chloride Workers.” Journal of Occupational and Environmental Medicine, 56(11): 1207–1209.CrossRefGoogle ScholarPubMed
Danieli, C., Moura, C. S., Pilote, L., Bernatsky, S., and Abrahamowicz, M.. 2023. “Importance of Accounting for Timing of Time-Varying Exposures in Association Studies: Hydrochlorothiazide and Non-Melanoma Skin Cancer.” Pharmacoepidemiology and Drug Safety, 32(12): 1411–1420.CrossRefGoogle ScholarPubMed
De Guire, Louise, Theriault, G., Iturra, Hilda, Provencher, Simone, Cyr, Diane, and Case, B. W.. 1988. “Increased Incidence of Malignant Melanoma of the Skin in Workers in a Telecommunications Industry.” British Journal of Industrial Medicine, 45(12): 824–828.Google Scholar
Dickie, Mark and Gerking, Shelby. 1996. “Formation of Risk Beliefs, Joint Production and Willingness to Pay to Avoid Skin Cancer.” Review of Economics and Statistics, 78(3): 451–463.CrossRefGoogle Scholar
Dodson, Ronald F., Graef, Russell, Shepherd, Sara, O’Sullivan, Michael, and Levin, Jeffrey. 2005. “Asbestos Burden in Cases of Mesothelioma From Individuals From Various Regions of the United States.” Ultrastructural Pathology, 29(5): 415–433.CrossRefGoogle ScholarPubMed
Durmus, N., Shao, Y., Arslan, A. A., Zhang, Y., Pehlivan, S., Fernandez-Beros, M. E., Umana, L., Corona, R., Smyth-Giambanco, S., Abbott, S. A., and Reibman, J.. 2020. “Characteristics of Cancer Patients in the World Trade Center Environmental Health Center.” International Journal of Environmental Research and Public Health 17(19): 7190.CrossRefGoogle ScholarPubMed
Emory, T. S., Maddox, J. C., and Kradin, R. L.. 2020. “Malignant Mesothelioma Following Repeated Exposures to Cosmetic Talc: A Case Series of 75 Patients.” American Journal of Industrial Medicine, 63(6): 484–489.CrossRefGoogle ScholarPubMed
Engzell, U. 1979. “Occupational Etiology and Nasal Cancer. An Internordic Project.” Acta Otolaryngology 360: 126–128.Google ScholarPubMed
Faig, Jennifer, Howard, Suzanne, Levine, Edward A., Casselman, Gary, Hesdorffer, Mary, and Ohar, Jill A.. 2015. “Changing Pattern in Malignant Mesothelioma Survival.” Translational Oncology, 8(1): 35–39.CrossRefGoogle ScholarPubMed
Firth, H. M., Elwood, J. M., Cox, B., and Herbison, G. P.. 1999. “Historical Cohort Study of a New Zealand Foundry and Heavy Engineering Plant.” Occupational and Environmental Medicine, 56(2): 134–138.CrossRefGoogle ScholarPubMed
Franic, Duska M., Pathak, Dev S., and Gafni, Amiram. 2005. “Quality-Adjusted Life Years Was a Poor Predictor of Women’s Willingness to Pay in Acute and Chronic Conditions: Results of a Survey.” Journal of Clinical Epidemiology, 58(3): 291–303.CrossRefGoogle ScholarPubMed
Gamel, John W., Weller, Edie A., Wesley, Margaret N., and Feuer, Eric J.. 2000. “Parametric Cure Models of Relative and Cause-Specific Survival for Grouped Survival Times.” Computer Methods and Programs in Biomedicine, 61: 99–110.CrossRefGoogle ScholarPubMed
Gayer, Ted, Hamilton, James T., and Viscusi, W. Kip. 2000. “Private Values of Risk Tradeoffs at Superfund Sites: Housing Market Evidence on Learning About Risk.” Review of Economics and Statistics, 82(3): 439–451.CrossRefGoogle Scholar
Gerking, Shelby, Adamowicz, Wiktor, Dickie, Mark, and Veronesi, Marcella. 2017. “Baseline Risk and Marginal Willingness to Pay for Health Risk Reduction.” Journal of Risk and Uncertainty, 55(2–3): 177–202.CrossRefGoogle ScholarPubMed
Gerking, Shelby, Dickie, Mark, and Veronesi, Marcella. 2012. “Valuation of Human Health: An Integrated Model of Willingness to Pay for Mortality and Morbidity Risk Reductions.” Journal of Environmental Economics and Management, 68(1): 20–45.CrossRefGoogle Scholar
Gerking, Shelby, Dickie, Mark, and Veronesi, Marcella. 2014. “Valuation of Human Health: An Integrated Model of Willingness to Pay for Mortality and Morbidity Risk Reductions.” Journal of Environmental Economics and Management, 68(1): 20–45.CrossRefGoogle Scholar
Golka, Klaus, Kopps, Silke, Prager, Hans-Martin M., Mende, Stephan V., Thiel, Ralf, Jungmann, Olaf, Zumbe, Jurgen, Bolt, Hermann M., Blaszkewicz, Meinolf, Hengstler, Jan G., and Selinski, Silvia. 2012. “Bladder Cancer in Crack Testers Applying Azo Dye-Based Sprays to Metal Bodies.” Journal of Toxicology and Environmental Health, Part A, 75(8–10): 566–571.CrossRefGoogle ScholarPubMed
Haber, Steven E. and Haber, Jason M.. 2011. “Malignant Mesothelioma: A Clinical Study of 238 Cases.” Industrial Health, 49(2): 166–172.CrossRefGoogle ScholarPubMed
Hammitt, James K. and Haninger, Kevin. 2010. “Valuing Fatal Risks to Children and Adults: Effects of Disease, Latency, and Risk Aversion.” Journal of Risk and Uncertainty, 40(1): 57–83.CrossRefGoogle Scholar
Hammitt, James K. and Haninger, Kevin. 2017. “Valuing Nonfatal Health Risk as a Function of Illness Severity and Duration: Benefit Transfer Using QALYs.” Journal of Environmental Economics and Management, 82: 17–38.CrossRefGoogle Scholar
Hammitt, James K. and Liu, Jin-Tan. 2004. “Effects of Disease Type and Latency on the Value of Mortality Risk.” Journal of Risk and Uncertainty, 28(1): 73–95.CrossRefGoogle Scholar
Hammitt, James and Zhou, Ying. 2006. “The Economic Value of Air-Pollution-Related Health Risks in China: A Contingent Valuation Study.” Environmental & Resource Economics, 33(3): 399–423.CrossRefGoogle Scholar
Hicks, Blánaid, Kaye, James A., Azoulay, Laurent, Bruun Kristensen, Kasper, Habel, Laurel A., and Pottegård, Anton. 2023. “The Application of Lag Times in Cancer Pharmacoepidemiology: A Narrative Review.” Annals of Epidemiology, 84: 25–32.CrossRefGoogle ScholarPubMed
Hillerdal, G., Karlen, E., and Aberg, T.. 1983. “Tobacco Consumption and Asbestos Exposure in Patients With Lung Cancer: A Three Year Prospective Study.” British Journal of Industrial Medicine, 40(4): 380–383.Google ScholarPubMed
Howard, John. 2015. Minimum Latency & Types or Categories of Cancer. Atlanta, GA: World Trade Center Health Program.Google Scholar
Huh, D. A., Chae, W. R., Choi, Y. H., Kang, M. S., Lee, Y. J., and Moon, K. W. 2022. “Disease Latency according to Asbestos Exposure Characteristics among Malignant Mesothelioma and Asbestos-Related Lung Cancer Cases in South Korea.” International Journal of Environmental Research and Public Health, 19(23): 15934.CrossRefGoogle ScholarPubMed
Huh, D. A., Kang, M. S., Lee, J., Choi, J. Y., Moon, K. W., and Lee, Y. J.. 2021. “Occupational and Environmental Asbestos Exposure and the Risk of Lung Cancer in Korea: A Case-Control Study in South Chungcheong Province of Korea.” PLoS One, 16(4): e0249790.CrossRefGoogle ScholarPubMed
Hyland, Rebecca A., Ware, Sandra, Johnson, Anthony R., and Yates, Deborah H.. 2007. “Incidence Trends and Gender Differences in Malignant Mesothelioma in New South Wales, Australia.” Scandinavian Journal of Work, Environment & Health, 33(4): 286–292.CrossRefGoogle ScholarPubMed
Jeanrenaud, Claude, Priez, France, and Vannotti, Marco. 2001. “Valuing the Intangible Costs of Cirrhosis of the Liver: A Two-Step Procedure.” Schweizerische Zeitschrift fur Volkswirtschaft und Statistik/Swiss Journal of Economics and Statistics, 137(1): 87–102.Google Scholar
Jones, R. D., Smith, D. M., and Thomas, P. G.. 1988. “A Mortality Study of Vinyl Chloride Monomer Workers Employed in the United Kingdom in 1940-1974.” Scandinavian Journal of Work, Environment & Health, 14(3): 153–160.CrossRefGoogle ScholarPubMed
Kagan, Elliott and Jacobson, Robert J.. 1983. “Lymphoid and Plasma Cell Malignancies: Asbestos-Related Disorders of Long Latency.” American Journal of Clinical Pathology, 80(1): 14–20.CrossRefGoogle ScholarPubMed
Kane, Michael J., Chahinian, A. Philippe, and Holland, James F.. 1990. “Malignant Mesothelioma in Young Adults.” Cancer, 65(6): 1449–1455.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Karjalainen, A., Meurman, L. O., and Pukkala, E.. 1994. “Four Cases of Mesothelioma Among Finnish Anthophyllite Miners.” Occupational and Environmental Medicine, 51(3): 212–215.CrossRefGoogle ScholarPubMed
Kim, Tae-Woo, Koh, Dong-Hee, and Park, Chung-Yill. 2010. “Decision Tree of Occupational Lung Cancer Using Classification and Regression Analysis.” Safety and Health at Work, 1(2): 140–148.CrossRefGoogle ScholarPubMed
Kishimoto, Takumi, Gemba, Kenichi, Fujimoto, Nobukazu, Onishi, Kazuo, Usami, Ikuji, Mizuhashi, Keiichi, and Kimura, Kiyonobu. 2010. “Clinical Study of Asbestos-Related Lung Cancer in Japan With Special Reference to Occupational History.” Cancer Science, 101(5): 1194–1198.CrossRefGoogle ScholarPubMed
Kishimoto, Takumi, Okada, Keisei, Sato, Toshio, Ono, Tetsuya, and Ito, Hisaso. 1989. “Evaluation of the Pleural Malignant Mesothelioma Patients With the Relation of Asbestos Exposure.” Environmental Research, 48(1): 42–48.CrossRefGoogle ScholarPubMed
Klebe, S., Hocking, A. J., Soeberg, M., and Leigh, J.. 2021. “The Significance of Short Latency in Mesothelioma for Attribution of Causation: Report of a Case with Predisposing Germline Mutations and Review of the Literature.” International Journal of Environmental Research and Public Health, 18(24): 13310.CrossRefGoogle ScholarPubMed
Klubo-Gwiezdzinska, J. 2022. “Childhood Exposure to Excess Ionizing Radiation Is Associated with Dose-Dependent Fusions as Molecular Drivers of Papillary Thyroid Cancer.” Clinical Thyroidology, 34(4): 161–164.CrossRefGoogle ScholarPubMed
Koo, E., Henderson, M. A., Dwyer, M., and Skandarajah, A. R.. 2020. “Radiation-Associated Breast Cancers in a Late-Effects Cohort: Long-Term Surveillance Is Essential.” Asia-Pacific Journal of Clinical Oncology, 16(6): 363–371.CrossRefGoogle Scholar
Koskela, R. S., Klockars, M., Jarvinen, E., Kolari, P. J., and Rossi, A.. 1987. “Mortality and Disability Among Granite Workers.” Scandinavian Journal of Work, Environment & Health, 13(1): 18–25.CrossRefGoogle ScholarPubMed
Krupnick, Alan J. and Cropper, Maureen L.. 1992. “The Effect of Information on Health Risk Valuations.” Journal of Risk and Uncertainty, 5(1): 29–48.CrossRefGoogle Scholar
Lang, Hui-Chu, Chang, Koyin, and Ying, Yung-Hsiang. 2012. “Quality of Life, Treatments, and Patients’ Willingness to Pay for a Complete Remission of Cervical Cancer in Taiwan.” Health Economics, 21(10): 1217–1233.CrossRefGoogle ScholarPubMed
Lee, Jihye, Kang, Young Joong, Ahn, Jungho, and Song, Seng-Ho. 2017. “Indolent B-Cell Lymphoid Malignancy in the Spleen of a Man Who Handled Benzene: Splenic Marginal Zone Lymphoma.” Safety and Health at Work, 8(3): 315–317.CrossRefGoogle Scholar
Lelbach, Werner K. 1996. “A 25-Year Follow-Up Study of Heavily Exposed Vinyl Chloride Workers in Germany.” American Journal of Industrial Medicine, 29(5): 446–458.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Lindhjem, Henrik and Navrud, Ståle. 2008. “How Reliable Are Meta-Analyses for International Benefit Transfers?” Ecological Economics, 66(2–3): 425–435.CrossRefGoogle Scholar
Ma, Helen, Ricks-Oddie, Joni, Gupta, Pankaj, O’Brien, Susan, and Cozen, Wendy. 2022. “IBCL-349 Veterans With Agent Orange Exposure Have a Shorter Latency From Exposure to Diagnosis of Indolent B-Cell Lymphoid Malignancies Compared to Unexposed Veterans.” Clinical Lymphoma Myeloma and Leukemia, 22: S389–S390.CrossRefGoogle Scholar
Magat, Wesley A., Viscusi, W. Kip, and Huber, Joel. 1996. “A Reference Lottery Metric for Valuing Health.” Management Science, 42(8): 1118–1130.CrossRefGoogle Scholar
Malone, K. E. 1993. “Diethylstilbestrol (DES) and Breast Cancer.” Epidemiologic Reviews, 15(1): 108–109.CrossRefGoogle ScholarPubMed
Maltoni, C., Pinto, C., Valenti, D., Carnuccio, R., Amaducci, E., and Minardi, F.. 1995. “Mesotheliomas Following Exposure to Asbestos Used in Sugar Refineries: Report of 12 Italian Cases.” La Medicina del Lavoro, 86(5): 478–483.Google ScholarPubMed
Marczynski, B., Kraus, T., Rozynek, P., Raithel, H. J., and Baur, X.. 2000. “Association Between 8-Hydroxy-2′-Deoxyguanosine Levels in DNA of Workers Highly Exposed to Asbestos and Their Clinical Data, Occupational and Non-Occupational Confounding Factors, and Cancer.” Mutation Research, 468(2): 203–212.CrossRefGoogle ScholarPubMed
Marinaccio, Alessandro, Binazzi, Alessandra, Cauzillo, Gabriella, Cavone, Domenica, De Zotti, Renata, Ferrante, Pierpaolo, Gennaro, Valerio, Gorini, Giuseppe, Menegozzo, Massimo, Mensi, Carolina, Merler, Enzo, Mirabelli, Dario, Montanaro, Fabio, Musti, Marina, Pannelli, Franco, Romanelli, Antonio, Scarselli, Alberto, and Tumino, Rosario. 2007. “Analysis of Latency Time and Its Determinants in Asbestos Related Malignant Mesothelioma Cases of the Italian Register.” European Journal of Cancer, 43(18): 2722–2728.CrossRefGoogle ScholarPubMed
Marinaccio, Alessandro, Binazzi, Alessandra, Di Marzio, Davide, Scarselli, Alberto, Verardo, Marina, Mirabelli, Dario, Gennaro, Valerio, Mensi, Carolina, Merler, Enzo, Zotti, De Renata, Mangone, Lucia, Chellini, Elisabetta, Pascucci, Cristiana, Ascoli, Valeria, Menegozzo, Simona, Cavone, Domenica, Cauzillo, Gabriella, Nicita, Carmela, Melis, Massimo and Iavicoli, Sergio. 2010. “Incidence of Extrapleural Malignant Mesothelioma and Asbestos Exposure, From the Italian National Register.” Occupational & Environmental Medicine, 67(11): 760–765.CrossRefGoogle ScholarPubMed
Marinaccio, Alessandro, Binazzi, Alessandra, Di Marzio, Davide, Scarselli, Alberto, Verardo, Marina, Mirabelli, Dario, Gennaro, Valerio, Mensi, Carolina, Riboldi, Luciano, Merler, Enzo, De Zotti, Renata, Romanelli, Antonio, Chellini, Elisabetta, Silvestri, Stefano, Pascucci, Cristiana, Romeo, Elisa, Menegozzo, Simona, Musti, Marina, Cavone, Domenica, Cauzillo, Gabriella, Tumino, Rosario, Nicita, Carmela, Melis, Massimo, and Iavicoli, Sergio. 2012. “Pleural Malignant Mesothelioma Epidemic: Incidence, Modalities of Asbestos Exposure and Occupations Involved From the Italian National Register.” International Journal of Cancer, 130(9): 2146–2154.CrossRefGoogle ScholarPubMed
McDonald, Rebecca L., Chilton, Susan M., Chilton, Susan M., Jones-Lee, Michael W., and Metcalf, Hugh R. T.. 2016. “Dread and Latency Impacts on a VSL for Cancer Risk Reductions.” Journal of Risk and Uncertainty, 52(2): 137–161.CrossRefGoogle Scholar
Mendez-Vargas, Maria M., Lopez-Rojas, Pablo, Campos-Pujal, Guillermo A., Marin-Cotonieto, Irma A., Salinas-Tovar, Santiago, and Fernandez-Munoz, Maria de Jesus. 2010. “Pleural Mesothelioma in Paraoccupational, Environmental and Occupational Patients Exposed to Asbestos.” Revista Medica del Instituto Mexicano del Seguro Social, 48(4): 361–366.Google ScholarPubMed
Miller, Albert. 2005. “Mesothelioma in Household Members of Asbestos-Exposed Workers: 32 United States Cases Since 1990.” American Journal of Industrial Medicine, 47(5): 458–462.CrossRefGoogle ScholarPubMed
Moline, J., Patel, K., and Frank, A. L.. 2023. “Exposure to Cosmetic Talc and Mesothelioma.” Journal of Occupational Medicine and Toxicology, 18(1): 1.CrossRefGoogle ScholarPubMed
Nakashima, H., Takatsu, T., and Imai, R.. 2022. “Radiation-Induced Osteosarcoma in the Pubic Bone After Proton Radiotherapy for Prostate Cancer: A Case Report.” Journal of Rural Medicine, 17(2): 94–100.CrossRefGoogle ScholarPubMed
National Science and Technology Council. 2023. Advancing the Frontiers of Benefit-Cost Analysis. Washington, DC: Federal Priorities and Directions for Future Research.Google Scholar
Neumann, V., Gunthe, S., Mulle, K. M., and Fischer, M.. 2001. “Malignant Mesothelioma—German Mesothelioma Register 1987-1999.” International Archives of Occupational and Environmental Health, 74(6): 383–395.CrossRefGoogle ScholarPubMed
Nielsen, Jytte Seested, Gyrd-Hansen, Dorte, and Kjær, Trine. 2012. “Valuation of Morbidity and Mortality Risk Reductions. Does context matter?.” Accident Analysis & Prevention, 48: 246–253.CrossRefGoogle ScholarPubMed
Pacini, F., Vorontsova, T., Demidchik, Eugeni P., Molinaro, Eleonora, Agate, Laura, Romei, Cristina, Shavrova, Elena, Cherstvoy, Eugeny D., Ivashkevitch, Yuriy, Kuchinskaya, Elvira, Schlumberger, Martin, Ronga, Giuseppe, Filesi, Mauro, and Pinchera, Aldo. 1997. “Post-Chernobyl Thyroid Carcinoma in Belarus Children and Adolescents: Comparison With Naturally Occurring Thyroid Carcinoma in Italy and France.” Journal of Clinical Endocrinology & Metabolism, 82(11): 3563–3569.Google ScholarPubMed
Patel, A. A., Rojek, A. E., Drazer, M. W., Weiner, H., Godley, L. A., Le Beau, M. M., and Larson, R. A.. 2021. “Therapy-Related Myeloid Neoplasms in 109 Patients After Radiation Monotherapy.” Blood Advances, 5(20): 4140–4148.Google ScholarPubMed
Polednak, Anthony P. 1978. “Bone Cancer Among Female Radium Dial Workers. Latency Periods and Incidence Rates by Time After Exposure: Brief Communication.” Journal of the National Cancer Institute, 60(1): 77–82.CrossRefGoogle ScholarPubMed
Popp, W., Schmieding, W., Speck, M., Vahrenholz, C., and Norpoth, K.. 1992. “Incidence of Bladder Cancer in a Cohort of Workers Exposed to 4-Chloro-o-Toluidine While Synthesising Chlordimeform. British Journal of Industrial Medicine, 49(8): 529–531.Google Scholar
Porzio, A., Feola, A., Parisi, G., Lauro, A., and Campobasso, C. P.. 2023. “Colorectal Cancer: 35 Cases in Asbestos-Exposed Workers.” Healthcare (Basel), 11(23): 3077.CrossRefGoogle ScholarPubMed
Priez, France and Jeanrenaud, Claude. 1999. “Human Costs of Chronic Bronchitis in Switzerland.” Schweizerische Zeitschrift fur Volkswirtschaft und Statistik/Swiss Journal of Economics and Statistics, 135(3): 287–301.Google Scholar
Ready, Richard, Navrud, Ståle, Day, Brett, Dubourg, Richard, Machado, Fernando, Mourato, Susana, Spanninks, Frank, and Vázquez Rodriquez, Maria Xosé. 2004. “Benefit Transfer in Europe: How Reliable Are Transfers Between Countries?” Environmental and Resource Economics, 29(1): 67–82.CrossRefGoogle Scholar
Revesz, Richard L. 1999. “Environmental Regulation, Cost-Benefit Analysis, and the Discounting of Human Lives.” Columbia Law Rev 99: 941.CrossRefGoogle ScholarPubMed
Rheinberger, Christoph M., Herrera-Araujo, Daniel, and Hammitt, James K.. 2016. “The Value of Disease Prevention vs Treatment.” Journal of Health Economics, 50: 247–255.CrossRefGoogle ScholarPubMed
Robinson, Lisa A and Hammitt, James K. 2016. “Valuing Reductions in Fatal Illness Risks: Implications of Recent Research.” Health Economics, 25(8): 1039–1052.CrossRefGoogle ScholarPubMed
Roguin, Ariel, Goldstein, Jacob, Bar, Olivier, and Goldstein, James A.. 2013. “Brain and Neck Tumors Among Physicians Performing Interventional Procedures.” The American Journal of Cardiology, 111(9): 1368–1372.CrossRefGoogle ScholarPubMed
Rowell, Arden. 2010. “The Cost of Time: Haphazard Discounting and the Undervaluation of Regulatory Benefits.” Notre Dame Law Review, 85: 1505.Google Scholar
Rubino, Giovanni F., Scansetti, Giovanni, Piolatto, Giorgio, and Pira, Enrico. 1982. “The Carcinogenic Effect of Aromatic Amines: An Epidemiological Study on the Role of o-Toluidine and 4,4′-Methylene Bis (2-Methylaniline) in Inducing Bladder Cancer in Man.” Environmental Research, 27(2): 241–254.CrossRefGoogle ScholarPubMed
Schulte, Paul A., Ringen, Knut, Hemstreet, George P., Altekruse, Ernest B., Gullen, Warren H., Patton, Maurice G., Allsbrook, William C. Jr., Crosby, John H., West, Seymour S., Witherington, Roy, Koss, Leopold, Bales, Carol E., Tillet, Sandra, Rooks, Shirley, Stern, Frank, Stringer, William, Schmidt, Verleen A., and Brubaker, Margaret M.. 1985. “Risk Assessment of a Cohort Exposed to Aromatic Amines. Initial Results.” Journal of Occupational and Environmental Medicine, 27(2): 115–121.Google ScholarPubMed
Science Advisory Board (SAB). 2001. Arsenic Rule Benefits Analysis: An SAB Review. A Review by the Arsenic Rule Benefits Review Panel (ARBRP) of the US EPA Science Advisory Board (SAB). Washington, DC: EPA Science Advisory Board.Google Scholar
Science Advisory Board (SAB). 2011. Review of Valuing Mortality Risk Reductions for Environmental Plicy: A White Paper (December 10, 2010).Google Scholar
Science Advisory Board (SAB). 2017. SAB Review of EPA’s Proposed Methodology for Updating Mortality Risk Valuation Estimates for Policy Analysis.Google Scholar
Science Advisory Board (SAB). 2024. Review of BenMAP and Benefits Methods.Google Scholar
Shum, E., Durmus, N., Pehlivan, S., Lu, Y., Zhang, Y., Arslan, A. A., Shao, Y., and Reibman, J.. 2022. “Characteristics of Women With Lung Adenocarcinoma in the World Trade Center Environmental Health Center.” International Journal of Environmental Research and Public Health, 19(13): 7618.CrossRefGoogle ScholarPubMed
Skammeritz, E., Omland, L. H., Johansen, J. P., and Omland, O.. 2011. “Asbestos Exposure and Survival in Malignant Mesothelioma: A Description of 122 Consecutive Cases at an Occupational Clinic.” International Journal of Occupational and Environmental Medicine, 2(4): 224–236.Google Scholar
Sloan, Frank A. 1998. “Alternative Approaches to Valuing Intangible Health Losses: The Evidence for Multiple Sclerosis.” Journal of Health Economics, 17(4): 475–497.CrossRefGoogle ScholarPubMed
Smoll, Nicolas R., Mathews, John D., and Scurrah, Katrina J.. 2020. “CT Scans in Childhood Predict Subsequent Brain Cancer: Finite Mixture Modelling Can Help Separate Reverse Causation Scans From Those That May Be Causal.” Cancer Epidemiology, 67: 101732.CrossRefGoogle ScholarPubMed
Stavem, Knut. 1999. “Willingness to Pay: A Feasible Method for Assessing Treatment Benefits in Epilepsy?” Seizure: European Journal of Epilepsy, 8(1): 14–19.CrossRefGoogle Scholar
Sunstein, Cass R. and Zeckhauser, Richard. 2011. “Overreaction to Fearsome Risks.” Environmental and Resource Economics, 48(3): 435–449.CrossRefGoogle Scholar
Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) (2024) Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence – SEER Research Data, 17 Registries, Nov 2023 Sub (2000–2021) – Linked To County Attributes – Time Dependent (1990–2022) Income/Rurality, 1969–2022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission.Google Scholar
Tokudome, S. and Kuratsune, M.. 1983. “Mortality From Cancer and Other Causes Among Workers at a Metal Refinery.” Journal of Uoeh, 5: 101–108.Google Scholar
U.S. Bureau of Economic Analysis. 2024. Real Gross Domestic Product Per Capita [A939RX0Q048SBEA], Retrieved From FRED, Federal Reserve Bank of St. Louis.Google Scholar
U.S. Bureau of Labor Statistics (U.S. BLS). 2024. Consumer Price Index for All Urban Consumers. U.S. City Average (CUSR0000SA0).Google Scholar
U.S. Census Bureau. 2014–2023. Current Population Survey. Annual Social and Economic (ASEC) Supplement Survey 2014–2023.Google Scholar
U.S. Department of Health and Human Services (HHS). 2016. Guidelines for Regulatory Impact Analysis. Washington, DC: Office of the Assistant Secretary for Planning and Evaluation.Google Scholar
U.S. Department of Health and Human Services (HHS). 2021. Appendix D: Updating Value per Statistical Life (VSL) Estimates for Inflation and Changes in Real Income, April 2021.Google Scholar
U.S. Department of Transportation (DOT). 2024. Departmental Guidance on Valuation of a Statistical Life in Economic Analysis. July 3, 2024. https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis.Google Scholar
U.S. Environmental Protection Agency (EPA). 2005. Economic Analysis for the Final Stage 2 Disinfectants and Disinfection Byproducts Rule. Office of Water. EPA 815-R-05-010, December 2005.Google Scholar
U.S. Environmental Protection Agency (EPA). 2010. Valuing Mortality Risk Reductions for Environmental Policy: A White Paper. Washington, DC: National Center for Environmental Economics.Google Scholar
U.S. Environmental Protection Agency (EPA). 2013. Economic Analysis of the Formaldehyde Standards for Composite Wood Products Act Implementing Regulations Proposed Rule. Washington, DC: Office of Chemical Safety and Pollution Prevention.Google Scholar
U.S. Environmental Protection Agency (EPA). 2014. Guidelines for Preparing Economic Analyses. Washington, DC: National Center for Environmental Economics. Office of Policy.Google Scholar
U.S. Environmental Protection Agency (EPA). 2016. Economic Analysis of Proposed TSCA Section 6 Action on Trichloroethylene in Dry Cleaning Spot Removers and Aerosol Degreasers. Washington, DC: Chemistry Economics & Sustainable Strategies Division.Google Scholar
U.S. Environmental Protection Agency (EPA). 2017. Economic Analysis of Proposed TSCA Section 6 Action on Trichloroethylene in Vapor Degreasing. Chemistry Economics & Sustainable Strategies Division, EPA Docket EPA HQ OPPT 2016 0387; RIN2070 AK11.Google Scholar
U.S. Environmental Protection Agency (EPA). 2019. Economic Analysis of Regulation of Methylene Chloride Paint and Coating Remover Under TSCA Section 6(a). Washington, DC: Chemistry Economics & Sustainable Strategies Division.Google Scholar
U.S. Environmental Protection Agency (EPA). 2021. Environmental Benefits Mapping and Analysis Program – Community Edition User’s Manual. Washington, DC: Office of Air Quality Planning and Standards.Google Scholar
U.S. Environmental Protection Agency (EPA). 2023. Environmental Benefits Mapping and Analysis Program – Community Edition. User’s Manual. March 2023. Updated for BenMap-CE Version 1.5.8.Google Scholar
U.S. Environmental Protection Agency (EPA). 2024. “IRIS Glossary.” July 12, 2024. https://www.epa.gov/iris/iris-glossary.Google Scholar
van der Bij, S., Koffijberg, H., Burgers, J. A., Baas, P., van de Vijver, M. J., de Mol, B. A, and Moons., K. G. 2012. “Prognosis and Prognostic Factors of Patients With Mesothelioma: A Population-Based Study.” British Journal of Cancer, 107(1): 161–164.CrossRefGoogle ScholarPubMed
Van Houtven, George, Sullivan, Melonie B, and Dockins, Chris. 2008. “Cancer Premiums and Latency Effects: A Risk Tradeoff Approach for Valuing Reductions in Fatal Cancer Risks.” Journal of Risk and Uncertainty, 36: 179–199.CrossRefGoogle Scholar
Vimercati, L., Cavone, D., Delfino, M. C., Caputi, A., De Maria, L., Sponselli, S., Corrado, V., Ferri, G. M., and Serio, G.. 2020. “Asbestos Air Pollution: Description of a Mesothelioma Cluster Due to Residential Exposure from an Asbestos Cement Factory.” International Journal of Environmental Research and Public Health, 17(8): 2636.CrossRefGoogle ScholarPubMed
Viscusi, W. Kip. 2018. “Best Estimate Selection Bias in the Value of a Statistical Life.” Journal of Benefit-Cost Analysis, 9(2): 205–246.CrossRefGoogle Scholar
Viscusi, W. Kip, Huber, Joel, and Bell, Jason. 2014. “Assessing Whether There Is a Cancer Premium for the Value of a Statistical Life.” Health Economics, 23(4): 384–396.CrossRefGoogle ScholarPubMed
Viscusi, W. Kip, Magat, Wesley A., and Huber, Joel. 1991. “Pricing Environmental Health Risks: Survey Assessments of Risk-Risk and Risk-Dollar Trade-Offs for Chronic Bronchitis.” Environmental Economics and Management, 21(1): 32–51.Google Scholar
Visonà, S. D., Capella, S., Bodini, S., Borrelli, P., Villani, S., Crespi, E., Colosio, C., Previderè, C., and Belluso, E.. 2021. “Evaluation of Deposition and Clearance of Asbestos (Detected by SEM-EDS) in Lungs of Deceased Subjects Environmentally and/or Occupationally Exposed in Broni (Pavia, Northern Italy).” Front Public Health, 9: 678040.CrossRefGoogle ScholarPubMed
Visonà, S. D., Capella, S., Borrelli, P., Villani, S., Favaron, C., Kurzhunbaeva, Z., Colosio, C., and Belluso, E.. 2023. “Asbestos Burden in Lungs of Non-Occupationally Exposed Women From Broni (Pavia, Italy): A Postmortem SEM-EDS Study.” The Journal of Thoracic Disease, 15(12): 6555–6569.CrossRefGoogle ScholarPubMed
Warnock, Martha L. and Isenberg, William. 1986. “Asbestos Burden and the Pathology of Lung Cancer.” Chest, 89(1): 20–26.CrossRefGoogle ScholarPubMed
Weistenhofer, Wobbeke, Blaszkewicz, Meinolf, Bolt, Hermann M., and Golka, Klaus. 2008. “N-Acetyltransferase-2 and Medical History in Bladder Cancer Cases With a Suspected Occupational Disease (BK 1301) in Germany.” Journal of Toxicology and Environmental Health, Part A, 71(13–14): 906–910.CrossRefGoogle ScholarPubMed
White House Office of Management and Budget (OMB). 2023a. Circular A-4, November 9, 2023.Google Scholar
White House Office of Management and Budget (OMB). 2023b. Circular A-94, November 9, 2023.Google Scholar
Wolf, J., Schmezer, P., Fengel, D., Schroeder, H. G., Scheithauer, H., and Woeste, P.. 1998. “The Role of Combination Effects on the Etiology of Malignant Nasal Tumours in the Wood-Working Industry.” Acta Otolaryngology, 535: 1–16.Google ScholarPubMed
Yeung, Paul, Rogers, Alan, and Johnson, Anthony. 1999. “Distribution of Mesothelioma Cases in Different Occupational Groups and Industries in Australia, 1979-1995.” Applied Occupational and Environmental Hygiene, 14(11): 759–767.CrossRefGoogle ScholarPubMed
Zhai, Guofang. 2011. “International Differences in Willingness to Pay for Reduced Risks Due to Risk Representation: Evidence From Cross-Country Surveys in Northeast Asia.” Journal of Risk Research, 14(10): 1177–1190.CrossRefGoogle Scholar
Zhang, Jing, Adamowicz, Wiktor, Dupont, Diane P., and Krupnick, Alan. 2013. “Assessing the Extent of Altruism in the Valuation of Community Drinking Water Quality Improvements.” Water Resources Research, 49(10): 6286–6297.CrossRefGoogle Scholar
Zhao, X., Chen, M., Qi, X., Zhu, H., Yang, G., Guo, Y., Dong, Q., and Yang, Q.. 2021. “Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult.” Front Endocrinol (Lausanne), 12: 805194.CrossRefGoogle ScholarPubMed
Zurnadzhy, L., Bogdanova, T., Rogounovitch, T. I., Ito, M., Tronko, M., Yamashita, S., Mitsutake, N., Bolgov, M., Chernyshov, S., Masiuk, S., and Saenko, V. A.. 2022. “Clinicopathological Implications of the BRAF (V600E) Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident.” Front Med (Lausanne), 9: 882727.CrossRefGoogle Scholar